Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
64,6 GBX | -0,62% | -0,92% | -3,58% |
26/03 | Earnings Flash (NIOX.L) NIOX GROUP rapporteert FY23 omzet GBP36.8M | MT |
26/03 | NIOX Group Plc rapporteert resultaten voor het volledige jaar eindigend op 31 december 2023 | CI |
Vakgebied
Aantal werknemers: 92
Verkoop per activiteit
GBP in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
NIOX
100,0
%
| 31 | 100,0 % | 37 | 100,0 % | +17,57% |
Verkoop per regio
GBP in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Asia Pacific
37,5
%
| 11 | 34,2 % | 14 | 37,5 % | +28,97% |
European Union
28,0
%
| 10 | 30,4 % | 10 | 28,0 % | +8,42% |
United States
23,6
%
| 8 | 25,9 % | 9 | 23,6 % | +7,41% |
United Kingdom
9,0
%
| 3 | 8,9 % | 3 | 9,0 % | +17,86% |
Rest of World
1,9
%
| 0 | 0,6 % | 1 | 1,9 % | +250,00% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Roller
DFI | Director of Finance/CFO | 59 | 09-01-20 |
Jan Lundquist
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jonathan Emms
COO | Chief Operating Officer | - | 02-09-19 |
Investor Relations Contact | - | 01-11-20 | |
Nina Kataria
HRO | Human Resources Officer | - | 01-06-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ian Johnson
CHM | Chairman | 71 | 05-12-19 |
Michael Roller
DFI | Director of Finance/CFO | 59 | 09-01-20 |
Garry Watts
BRD | Director/Board Member | 67 | 02-03-20 |
Jonathan Emms
COO | Chief Operating Officer | - | 02-09-19 |
Director/Board Member | 60 | 08-02-18 | |
Sharon Curran
BRD | Director/Board Member | 56 | 08-02-18 |
Director/Board Member | 34 | 13-11-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 422 746 703 | 193 521 145 ( 45,78 %) | 0 | 45,78 % |
Bedrijfsgegevens
Niox Group Plc
Hayakawa Building The Oxford Science Park
OX4 4GB, Oxford
+44 3303 309 356
http://www.niox.comBedrijven van de groep
Naam | Categorie en sector |
---|---|
Circassia Ltd.
Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. |
Pharmaceuticals: Other
|
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,58% | 343 mln. | |
+27,97% | 676 mld. | |
+23,58% | 554 mld. | |
-7,02% | 349 mld. | |
+14,85% | 318 mld. | |
+6,25% | 291 mld. | |
+2,96% | 210 mld. | |
-0,41% | 204 mld. | |
-10,02% | 194 mld. | |
-11,81% | 144 mld. |